Hydroxychloroquine No Aid for COVID-Related Mortality
Hydroxychloroquine alone or with azithromycin associated with abnormal electrocardiogram findings
Guidance Issued for Osteoporosis Management During COVID-19
Alternative methods for parenteral treatments include off-site clinics, home visit, self-injection
Experimental COVID-19 Vaccine Appears Safe, Triggers Immune Response
Findings from early-stage trial that started in March and included eight healthy people receiving two doses
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants
Addition of Atezolizumab May Aid in Metastatic Urothelial Cancer
Phase 3 trial shows prolonged progression-free survival for atezolizumab plus platinum-based chemo
Interferon-α2b May Shorten Viral Shedding Duration in COVID-19
Duration of elevated blood levels for inflammatory markers IL-6, C-reactive protein also reduced
ACP Advises Against Chloroquine, Hydroxychloroquine for COVID-19
Practice points based on lack of evidence supporting use as prophylaxis or treatment for COVID-19
NIH: Large-Scale Testing of Some COVID-19 Vaccines Could Start in July
About a dozen potential vaccines worldwide are in the initial stages of, or set to begin, testing in people
NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID-19
Trial will enroll 2,000 patients with SARS-COV-2 who have fever, cough, and/or shortness of breath
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
